IRIS
DE FABRITIIS, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.035
AS - Asia 5.176
EU - Europa 3.696
SA - Sud America 815
Continente sconosciuto - Info sul continente non disponibili 518
AF - Africa 71
OC - Oceania 12
Totale 46.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.839
SG - Singapore 2.540
CN - Cina 836
RU - Federazione Russa 694
IT - Italia 691
BR - Brasile 663
HK - Hong Kong 616
DE - Germania 597
VN - Vietnam 441
UA - Ucraina 436
IE - Irlanda 380
GB - Regno Unito 233
FR - Francia 187
BD - Bangladesh 185
JP - Giappone 177
FI - Finlandia 120
SE - Svezia 106
KR - Corea 95
CA - Canada 94
IN - India 65
MX - Messico 53
NL - Olanda 52
AR - Argentina 50
PL - Polonia 47
AT - Austria 37
TR - Turchia 31
IQ - Iraq 28
ZA - Sudafrica 24
EC - Ecuador 23
ES - Italia 22
ID - Indonesia 22
BE - Belgio 18
UZ - Uzbekistan 18
PY - Paraguay 17
PK - Pakistan 16
CL - Cile 15
CO - Colombia 14
PH - Filippine 13
CZ - Repubblica Ceca 12
RO - Romania 12
VE - Venezuela 11
AU - Australia 10
KE - Kenya 10
GR - Grecia 9
JM - Giamaica 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
IL - Israele 8
IR - Iran 8
LT - Lituania 8
MA - Marocco 8
CR - Costa Rica 7
JO - Giordania 7
KZ - Kazakistan 7
MY - Malesia 7
CH - Svizzera 6
EU - Europa 6
NI - Nicaragua 6
PT - Portogallo 6
SA - Arabia Saudita 6
BO - Bolivia 5
GT - Guatemala 5
HR - Croazia 5
NP - Nepal 5
QA - Qatar 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
DM - Dominica 4
HU - Ungheria 4
KG - Kirghizistan 4
SN - Senegal 4
SV - El Salvador 4
TW - Taiwan 4
AL - Albania 3
GY - Guiana 3
NG - Nigeria 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UY - Uruguay 3
AM - Armenia 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
LB - Libano 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
Totale 45.793
Salva come PNG Salva come JPEG
Città #
Woodbridge 9.465
Wilmington 8.704
Houston 7.496
Singapore 1.393
Fairfield 1.120
Ann Arbor 869
Ashburn 867
San Jose 713
Chandler 617
Hong Kong 604
Seattle 472
Cambridge 394
Jacksonville 378
Dublin 361
Beijing 339
Medford 267
Council Bluffs 258
Santa Clara 258
New York 251
The Dalles 213
Dearborn 210
Rome 194
Los Angeles 172
Dallas 169
Ho Chi Minh City 155
Tokyo 149
Lawrence 128
Moscow 124
Buffalo 110
Hanoi 99
Colorado Springs 94
Lauterbourg 91
Zhengzhou 78
San Diego 65
Mülheim 64
São Paulo 64
Milan 62
Menlo Park 45
Munich 45
London 35
Corona 34
Montreal 34
Chicago 32
Brooklyn 27
Boardman 26
Helsinki 26
Nuremberg 26
Norwalk 25
Denver 24
Frankfurt am Main 24
Redondo Beach 24
Bologna 23
Phoenix 23
Toronto 23
University Park 23
Orem 22
Warsaw 22
Atlanta 21
Mexico City 20
Falls Church 19
Johannesburg 19
Brussels 18
Naples 18
Shanghai 18
Amsterdam 17
Chennai 17
Nanjing 17
Belo Horizonte 16
Hefei 16
Kraków 16
Mountain View 16
North Bergen 16
Rio de Janeiro 16
Verona 16
Vienna 16
Da Nang 15
Haiphong 15
Miami 14
Poplar 14
Stockholm 14
Washington 14
Redwood City 13
San Francisco 13
Turin 13
Boston 12
Brasília 12
Columbus 12
Kunming 12
Manchester 12
Baghdad 11
Mumbai 11
Salt Lake City 11
Seoul 11
Dhaka 10
Jakarta 10
Palo Alto 10
Chiswick 9
Creede 9
Curitiba 9
Guangzhou 9
Totale 38.237
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 641
Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978 515
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 501
Acute foetal distress and umbilical cord blood banking 500
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 489
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 484
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 477
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: Retrospective analysis of 530 patients 476
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 473
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry 471
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: Results of a randomized phase III trial of the EORTC and GIMEMA consortium (AML-17) 466
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 462
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease. 461
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components 460
IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. 460
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 458
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 452
Characterization of Ph-negative abnormal clones emerging during imatinib therapy 447
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 446
Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview 444
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 444
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 442
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 441
Management of hematological malignancies in patients affected by renal failure 440
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 440
Pure erythroid leukemia in advanced breast cancer. 440
Cutaneous involvement in multiple myeloma and bortezomib 437
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 437
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA) 434
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes 433
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 433
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 431
Evaluation of biological features of cord blood units collected with different methods after cesarean section 430
Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase 428
Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. 427
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 424
Cold autoimmune hemolytic anemia resolved by rituximab 423
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 423
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 421
Bortezomib-related colon mucositis in a multiple myeloma patient 420
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 419
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 418
Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting. 418
Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a previous malignancy: a comparison with the immunophenotype of 231 de novo cases 415
Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab. 414
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 412
Bortezomib: Efficacy comparisons in solid tumors and hematologic malignancies 412
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 411
Home care management of patients affected by hematologic malignancies: A review 410
null 410
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 407
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 405
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia 402
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 402
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow 401
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial 400
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion 399
Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia: In vitro and in vivo studies 398
Molecular evidence of transient complete remission after autografting in Ph-/bcr rearranged chronic myelogenous leukaemia 397
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 396
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 393
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures 390
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting 388
Opioids in pain management of blood-related malignancies 386
Sleep complaints in hospitalized Italian patients with hematological malignancies 385
null 385
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 382
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 378
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 378
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 377
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease 376
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 371
Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy? 368
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 366
Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence. 366
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 366
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 365
Stem cell mobilization after coronary artery bypass grafting. 364
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 363
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 358
Pain management in multiple myeloma. 334
Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient 333
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825. 331
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 315
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 297
Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series 297
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 296
Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Frontline Azacytidine Treatment 231
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 215
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions 210
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party 204
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy 199
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 192
Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score 186
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation 184
Bone marrow aspiration and biopsy-related pain management 182
Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need 178
Management of pregnant chronic myeloid leukemia patients 172
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network 172
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network 168
Totale 38.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.275
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.211 0 169 53 52 45 113 75 76 70 102 79 377
2022/20231.951 183 144 60 184 124 368 153 91 142 344 117 41
2023/2024916 97 30 79 41 115 217 31 49 25 24 42 166
2024/20253.775 115 895 417 219 137 180 353 142 377 389 280 271
2025/20266.514 547 421 835 529 625 229 823 663 783 559 288 212
2026/2027616 279 337 0 0 0 0 0 0 0 0 0 0
Totale 46.323